IQGAP2 was first classified as a tumor suppressor expressed in the liver and was reported to regulate the PI3K/Akt and Wnt/β-catenin signaling pathways (Gnatenko et al., 2013). This evidence concerns the gene IQGAP2 and neoplasm.